Stock Scorecard
Stock Summary for Usana Health Sciences Inc (USNA) - $43.14 as of 4/26/2024 3:54:19 PM EST
Total Score
17 out of 29
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for USNA
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for USNA
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for USNA
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for USNA
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for USNA
Financial Details for USNA
Company Overview |
|
|---|---|
| Ticker | USNA |
| Company Name | Usana Health Sciences Inc |
| Country | USA |
| Description | USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company is headquartered in Salt Lake City, Utah. |
| Sector Name | LIFE SCIENCES |
| Industry Name | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/1/2024 |
Stock Price History |
|
| Last Day Price | 43.14 |
| Last Day Price Updated | 4/26/2024 3:54:19 PM EST |
| Last Day Volume | 0 |
| Average Daily Volume | 91,410 |
| 52-Week High | 69.60 |
| 52-Week Low | 42.59 |
| Last Price to 52 Week Low | 1.29% |
Valuation Measures |
|
| Trailing PE | 13.17 |
| Industry PE | 13.32 |
| Sector PE | 56.64 |
| 5-Year Average PE | 12.39 |
| Free Cash Flow Ratio | 2.51 |
| Industry Free Cash Flow Ratio | 56.92 |
| Sector Free Cash Flow Ratio | 30.65 |
| Current Ratio Most Recent Quarter | 3.52 |
| Total Cash Per Share | 17.17 |
| Book Value Per Share Most Recent Quarter | 25.99 |
| Price to Book Ratio | 1.70 |
| Industry Price to Book Ratio | 2.22 |
| Sector Price to Book Ratio | 22.15 |
| Price to Sales Ratio Twelve Trailing Months | 0.92 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
| Total Shares Outstanding | 19,240,500 |
| Market Capitalization | 830,035,170 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.03% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 32.00% |
| Annual Earnings Growth | -8.02% |
| Reported EPS 12 Trailing Months | 3.30 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 3.30 |
| Net Income Twelve Trailing Months | 63,788,000 |
| Net Income Past Year | 63,788,000 |
| Net Income Prior Year | 69,350,000 |
| Quarterly Revenue Growth YOY | -3.00% |
| 5-Year Revenue Growth | -4.92% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 330,420,000 |
| Total Cash Past Year | 330,420,000 |
| Total Cash Prior Year | 288,420,000 |
| Net Cash Position Most Recent Quarter | 329,634,000 |
| Net Cash Position Past Year | 329,634,000 |
| Long Term Debt Past Year | 786,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 786,000 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 497,202,000 |
| Total Stockholder Equity Prior Year | 434,472,000 |
| Total Stockholder Equity Most Recent Quarter | 497,202,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.13 |
| MACD Signal | -1.09 |
| 20-Day Bollinger Lower Band | 43.08 |
| 20-Day Bollinger Middle Band | 48.64 |
| 20-Day Bollinger Upper Band | 54.19 |
| Beta | 0.91 |
| RSI | 35.32 |
| 50-Day SMA | 54.82 |
| 200-Day SMA | 73.83 |
System |
|
| Modified | 4/27/2024 1:51:37 PM EST |